Insider · CIK 0001187054

BEIER DAVID W

Reports to the SEC for 5 companies · THOUSAND OAKS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001187054

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-06-16	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2021-06-10	INFINITY PHARMACEUTICALS, INC.A Award	Director	AAward	+3,061 sh	$3.43	+$10.5K	8,775
2021-06-10	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2020-06-17	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2019-06-13	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2019-06-06	RCUSArcus Biosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2018-06-12	INFINITY PHARMACEUTICALS, INC.A Award	Director	AAward	+5,714 sh	$1.75	+$9,999.5	5,714
2018-04-01	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2012-05-03	AMGNAMGEN INCM Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	+10K sh	$50.44	+$504K	80,612
2012-05-03	AMGNAMGEN INCM Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	+1,598 sh	$62.55	+$100K	37,210
2012-05-03	AMGNAMGEN INC · Nqso (Right to Buy)M Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	−10K sh	—	—	20,000
2012-05-03	AMGNAMGEN INC · Nqso (Right to Buy)M Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	−10K sh	—	—	10,000
2012-05-03	AMGNAMGEN INCM Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	+23.4K sh	$62.55	+$1.46M	60,612
2012-05-03	AMGNAMGEN INCM Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	+10K sh	$58.43	+$584K	90,612
2012-05-03	AMGNAMGEN INCM Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	+10K sh	$42.13	+$421K	70,612
2012-05-03	AMGNAMGEN INC · Nqso (Right to Buy)M Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	−10K sh	—	—	0
2012-05-03	AMGNAMGEN INC · Nqso (Right to Buy)M Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	−23.4K sh	—	—	0
2012-05-03	AMGNAMGEN INC · Iso (Right to Buy)M Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	−1,598 sh	—	—	0
2012-05-03	AMGNAMGEN INCS Sale	SVP, Global Govt Affairs	SSale	−55K sh	$70.72	−$3.89M	35,612
2012-04-29	AMGNAMGEN INCF Tax Payment	SVP, Global Govt Affairs	FTax Payment	−1,267 sh	$71.64	−$90.8K	35,612
2012-04-28	AMGNAMGEN INCF Tax Payment	SVP, Global Govt Affairs	FTax Payment	−634 sh	$71.64	−$45.4K	36,879
2012-04-27	AMGNAMGEN INCA Award	SVP, Global Govt Affairs	AAward	+3,350 sh	—	—	37,513
2012-04-26	AMGNAMGEN INCF Tax Payment	SVP, Global Govt Affairs	FTax Payment	−645 sh	$70.19	−$45.3K	34,163
2012-03-16	AMGNAMGEN INCF Tax Payment	SVP, Global Govt Affairs	FTax Payment	−2,326 sh	$68.26	−$159K	34,808
2012-03-14	AMGNAMGEN INCA Award	SVP, Global Govt Affairs	AAward	+5,232 sh	—	—	37,134
2012-02-07	AMGNAMGEN INC · Nqso (Right to Buy)M Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	−10K sh	—	—	20,000
2012-02-07	AMGNAMGEN INCM Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	+10K sh	$58.43	+$584K	51,902
2012-02-07	AMGNAMGEN INCM Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	+10K sh	$50.44	+$504K	41,902
2012-02-07	AMGNAMGEN INC · Nqso (Right to Buy)M Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	−10K sh	—	—	30,000
2012-02-07	AMGNAMGEN INCS Sale	SVP, Global Govt Affairs	SSale	−20K sh	$68.88	−$1.38M	31,902
2012-01-27	AMGNAMGEN INCM Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	+30K sh	$42.13	+$1.26M	79,402
2012-01-27	AMGNAMGEN INCM Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	+17.5K sh	$58.61	+$1.03M	49,402
2012-01-27	AMGNAMGEN INC · Nqso (Right to Buy)M Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	−17.5K sh	—	—	0
2012-01-27	AMGNAMGEN INC · Nqso (Right to Buy)M Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	−10K sh	—	—	30,000
2012-01-27	AMGNAMGEN INC · Nqso (Right to Buy)M Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	−30K sh	—	—	10,000
2012-01-27	AMGNAMGEN INCS Sale	SVP, Global Govt Affairs	SSale	−57.5K sh	$68.47	−$3.94M	31,902
2012-01-27	AMGNAMGEN INCM Exercise/Conversion	SVP, Global Govt Affairs	MExercise/Conversion	+10K sh	$50.44	+$504K	89,402
2011-08-15	AMGNAMGEN INCS Sale	SVP, Global Govt Affairs	SSale	−15K sh	$51.56	−$773K	31,902
2011-04-29	AMGNAMGEN INCF Tax Payment	SVP, Global Govt Affairs	FTax Payment	−1,248 sh	$57.14	−$71.3K	46,902
2011-04-28	AMGNAMGEN INCF Tax Payment	SVP, Global Govt Affairs	FTax Payment	−561 sh	$56.82	−$31.9K	48,150
2011-04-26	AMGNAMGEN INCF Tax Payment	SVP, Global Govt Affairs	FTax Payment	−490 sh	$54.69	−$26.8K	48,711
2011-04-25	AMGNAMGEN INCA Award	SVP, Global Govt Affairs	AAward	+7,500 sh	—	—	49,201
2011-04-25	AMGNAMGEN INC · Nqso (Right to Buy)A Award	SVP, Global Govt Affairs	AAward	+26.3K sh	$54.69	+$1.44M	26,250
2011-03-11	AMGNAMGEN INCF Tax Payment	SVP, Global Govt Affairs	FTax Payment	−2,835 sh	$51.84	−$147K	41,701
2011-03-02	AMGNAMGEN INCA Award	SVP, Global Govt Affairs	AAward	+8,395 sh	—	—	44,536
2010-08-13	AMGNAMGEN INCD Disposition to Issuer	SVP, Global Govt Affairs	DDisposition to Issuer	−13K sh	$54.94	−$714K	36,141
2010-07-31	AMGNAMGEN INCF Tax Payment	SVP, Global Govt Affairs	FTax Payment	−11.1K sh	$54.53	−$604K	49,141
2010-04-30	ARYx Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+6,666 sh	—	—	6,666
2010-04-29	AMGNAMGEN INCF Tax Payment	SVP, Global Govt Affairs	FTax Payment	−974 sh	$58.18	−$56.7K	60,222
2010-04-28	AMGNAMGEN INCF Tax Payment	SVP, Global Govt Affairs	FTax Payment	−491 sh	$57.84	−$28.4K	61,196

Recent filings

Accepted (ET)
Jun 164
BEIER DAVID W0001140361-22-023321
SEC(opens sec.gov)
Jun 114
BEIER DAVID W0001140361-21-020650
SEC(opens sec.gov)
Jun 184
BEIER DAVID W0000899243-20-017001
SEC(opens sec.gov)
Jun 144
BEIER DAVID W0000899243-19-017004
SEC(opens sec.gov)
Jun 104
BEIER DAVID W0001209191-19-035740
SEC(opens sec.gov)
Jun 144
BEIER DAVID W0000899243-18-016527
SEC(opens sec.gov)
Apr 24
BEIER DAVID W0000899243-18-009133
SEC(opens sec.gov)
May 74
BEIER DAVID W0001127602-12-016070
SEC(opens sec.gov)
May 14
BEIER DAVID W0001127602-12-015243
SEC(opens sec.gov)

Companies

Address

ONE AMGEN CENTER DRIVE

THOUSAND OAKS, CA, 91320-1799